1
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Diabetes Mellitus, Type 2
1
Colorectal Neoplasms
1
Interventions
Cisplatin
3202
Cyclophosphamide
3195
Carboplatin
2977
Radiotherapy
2790
Paclitaxel
2718
Gemcitabine
2572
pembrolizumab
2384
Bevacizumab
2209
Docetaxel
2199
Fluorouracil
1851
Capecitabine
1831
Oxaliplatin
1742
Dexamethasone
1605
Nivolumab
1581
Doxorubicin
1501
Rituximab
1488
Magnetic Resonance Spectroscopy
1387
Etoposide
1346
Irinotecan
1248
Leucovorin
1226
Drug Therapy
1205
Cytarabine
1130
Pemetrexed
1076
fludarabine
1063
Specimen Handling
1016
Vincristine
964
Cetuximab
945
Trastuzumab
944
Prednisone
941
Lenalidomide
937
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Plant Proteins
×
Clear all
NCT03206827
2021-09-27
ScenoProt
University of Helsinki
Phase NA
Completed
147 enrolled